TNF and cancer: ASCO, American Society of Clinical Oncology; csDMARDS, conventional synthetic disease-modifying anti-rheumatic drugs; ESMO, European Society for Medical Oncology; ICI, immune-checkpoint inhibitor; NA, not addressed; NCCN, National Comprehensive Cancer Network; NSAIDs, non-steroidal anti-inflammatory drugs; SITC, Society for Immunotherapy of Cancer; IL, interleukin; TNF-α, tumor necrosis factor-alpha.